US FDA approves Mirati’s lung cancer drug Reutetrs Dec 15, 2022 Mirati was seeking approval for the drug for treating patients with advanced lung cancer who have stopped responding to other…
Novartis fails again to reuse anti-inflammatory drug to treat lung cancer Reuters Aug 17, 2022 The failure in the latest trial, called Canopy A, is a setback for Novartis after canakinumab failed in two separate studies last…
Glenmark gets USFDA nod for generic lung cancer drug Press Trust of India Jun 26, 2021 The company's product is the generic version of Boehringer Ingelheim Pharmaceuticals Inc's Ofev capsules
EU approves AstraZeneca’s Imfinzi for treatment of extensive-stage small cell lung cancer EP News Bureau Sep 1, 2020 Imfinzi, in combination with etoposide and either carboplatin or cisplatin, is also approved in the US, Japan and several other…